Stayble appoints Professor Hans Jörg Meisel as a member of the scientific advisory board

10 Mar 2021

Anders Lehmann, Chief Scientific Officer comments: “We are excited about the appointment of Prof. Meisel, a leading expert in advanced therapies for low back pain with a long-standing and extensive experience in spinal diseases. His appointment to Stayble’s scientific advisory board provides us with more expertise in clinical development and ensures that we always have first-hand insights from both key markets, US and Europe.”

Hans Jörg Meisel, MD, PhD, Prof., is Director of the Center of Neurosciences and the Chair of the Department of Neurosurgery at the BG-Clinic Bergmannstrost Halle, Berlin, Germany. Prof. Meisel was one of the founding members of AO Spine Europe and is currently one of the steering committee members of AO Spine Knowledge Forum Degenerative and leading the AOGO project, creating a guideline for using osteobiologics in patients with spinal degeneration.

Prof. Meisel is an inventor and designer of spinal implants, and developed the first biological disc repair transplantation system with autologus chondrocytes in 1995. He has since then expanded his clinical trial expertise by initiating the EU Project ‘RESPINE’ together with colleagues in 2016. Prof Meisel has also co-founded several organizations. For example, he is a founding member of the European Commission’s European Technology Platform Nanomedicine, where he also served as chair of the Working Group of Nanotechnologies for Regenerative Medicine. Due to his extensive knowledge, Prof. Meisel was appointed to become a Visiting Professor at the Department of Orthopedic Surgery at the Vrije University of Amsterdam in 2007 and became Honorary Professor at the Department for Health Sciences and Biomedicine at the Donau-University Krems in Austria in 2013.